Lycera Announces Presentations of Positive Preclinical Results for Lead Candidate LYC-30937 and for Selective Rho kinase Inhibitor Program at the 11th Congress of the European Crohn's and Colitis Organization (ECCO)
![The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe - touchONCOLOGY The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2013/08/www.touchendocrinology.com_sites_www.touchendocrinology.com_files_new1.jpg)
The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe - touchONCOLOGY
Biotherapy monitoring, a major area of interest at the European Crohn's and Colitis Organisation (ECCO) Congress
![ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry ( ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry (](https://medicalupdateonline.com/wp-content/uploads/2016/05/ECCO-2016-Part-1-ECCO-EFCCA-Pat-Guidelines.jpg)
ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry (
![ECCO2017: European Cancer Congress - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology ECCO2017: European Cancer Congress - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/d4f601fd211b016eed1346965cbbd8e92fa97881/ECCO2017%20600x450.png)